Comments
The extraordinary general meeting of Aurobindo Pharma Limited has approved a move to issue shares to Qualified Institutional Buyers up to an amount of $350 million.
The company in a statement to the BSE informed that the approval to issue shares under Qualified Institutional Placement (QIP) was secured at a meeting held on Wednesday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.